Meta Brings Hearing Aids to Smart Glasses, FDA Approves Hearing Enhancement Feature

Meta has officially added a new capability to its smart glasses: a hearing enhancement feature that has received clearance from the United States Food and Drug Administration (FDA). The feature turns Meta's glasses into hearing aids for people with mild to moderate hearing loss, using machine learning to amplify human speech and suppress background noise.

The move marks a new chapter for Meta, long known as a social media giant, as it ventures into medical devices. But Meta is not the first player. Apple, with AirPods Pro 2, was earlier cleared as an over-the-counter hearing aid, and Nuance offers similar smart glasses. Meta is betting on form factor: glasses that are already commonly worn every day are seen as more socially acceptable than conventional hearing aids.

The feature is not free. Meta offers a 30-day trial, after which users pay a one-time fee of US$149.99 or subscribe to Meta One. In the US, the cost qualifies for FSA/HSA. Meta claims the total cost, including the price of compatible glasses, is far cheaper than traditional hearing aids, which can reach thousands of dollars. The initial launch is scheduled in the US at the end of 2026, with expansion to other countries awaiting each country's medical device regulations.

Ravish Mehra, Director of Research Science at Meta, revealed that development of the feature began more than five years ago. According to him, glasses offer a unique audio platform with a microphone array, on-device computing, and better social acceptance. "Glasses are the ideal form factor," he said. Mehra added that one in six Americans experiences mild to moderate hearing loss, but only about 15% take action. Hearing aids are considered expensive, uncomfortable to wear all day, and still carry stigma.

"No one can tell just by looking at your glasses that you have hearing loss," Mehra said, emphasizing that this approach removes the embarrassment that often stops people from seeking help.

Meta claims to be the first manufacturer to bring a self-fitting hearing aid to glasses. The hearing test process is done through the Meta AI app and a phone, in just one to two minutes. Users listen to tones at various frequencies and indicate when the sound becomes audible, then the system builds a hearing profile showing the areas that need amplification. "You don't have to go anywhere to fit your glasses to your hearing profile," Mehra explained. This test was key to the FDA clearance, after Meta proved its performance was on par with professional fitting.

Technically, six microphones on the glasses capture surrounding sound, which is then amplified according to the hearing profile. A machine learning model trained to recognize human speech suppresses background noise. Everything is processed on-device with very low latency to avoid echo or distortion. There are two modes: 360 mode amplifies sound from all directions, while Focus mode suits environments like restaurants, where users want to hear the person across the table. The wide frame design of the glasses makes sound isolation easier than with microphones embedded in the ear.

The biggest challenge is not just amplifying sound, but overcoming feedback. The open-ear design means the speaker and microphone are not separated, so the system must detect and suppress feedback before it occurs, without reducing amplification. "If you can't cancel feedback, you'll hear a sharp sound," Mehra said. In addition, the feature must run on the glasses' limited computing power, so Meta had to pack it into a very small power "envelope."

Meta has not confirmed which glasses models support this feature, only mentioning minimum performance requirements. The launch schedule has also not been detailed beyond the end of 2026. Given the processing needs, the feature is likely absent from older models such as the first-generation Ray-Ban Meta. All demos at Meta Connect 2026 used the newer Meta Glasses.

Indonesian Context

For Indonesia, Meta's move opens both opportunities and challenges. The hearing aid market in the country is still dominated by high-priced imported products, while awareness of hearing health is relatively low. The presence of smart glasses with sound enhancement features could be a more affordable alternative and reduce stigma, especially among the productive age group. However, medical device regulations in Indonesia must adapt quickly. BPOM and the Ministry of Health need to prepare an approval pathway for consumer-based medical devices, including local clinical trials and safety standards. Without that, Indonesia will only be a delayed market, while neighboring countries such as Singapore and Malaysia could adopt first.

In addition, collaboration with local healthcare providers and audiologists is key. Meta needs to ensure that self-administered hearing tests through the app can be medically accounted for, especially for users with more complex hearing loss. The potential for integration with telemedicine is also attractive, allowing users to consult remotely after obtaining a hearing profile.

Going forward, the question is no longer whether this technology will arrive in Indonesia, but how quickly the regulatory and healthcare ecosystems are ready to accept it. If Meta is serious about the Southeast Asian market, it needs to partner with local players and adapt features to language needs and tropical acoustic environments. Without that step, these smart glasses will only be an expensive gadget for a select few, not an inclusive solution for millions of people with hearing loss in Indonesia.